HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Yoshikazu Sugimoto Selected Research

Topotecan (Hycamtin)

7/2011Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
1/2009Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.
3/2006Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development.
8/2005Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics.
1/2005Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
9/2004Gefitinib reverses breast cancer resistance protein-mediated drug resistance.
6/2004Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance.
9/2003Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
1/2003Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists.
6/2002C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Yoshikazu Sugimoto Research Topics

Disease

41Neoplasms (Cancer)
11/2015 - 06/2002
35Breast Neoplasms (Breast Cancer)
01/2014 - 02/2002
7Colorectal Neoplasms (Colorectal Cancer)
05/2009 - 10/2006
6Colonic Neoplasms (Colon Cancer)
07/2011 - 09/2004
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2010 - 09/2004
4Lung Neoplasms (Lung Cancer)
07/2011 - 05/2005
3Stomach Neoplasms (Stomach Cancer)
10/2006 - 07/2005
2Mastitis
09/2012 - 04/2006
2Leukemia
07/2011 - 11/2007
2Lymphoma (Lymphomas)
06/2009 - 06/2003
2Body Weight (Weight, Body)
05/2009 - 12/2006
2Carcinoma (Carcinomatosis)
06/2006 - 07/2005
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2006 - 08/2005
1Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2013
1Dystocia
01/2012
1Birth Weight (Birth Weights)
01/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2011
1Leukemia P388
07/2011
1Renal Cell Carcinoma (Grawitz Tumor)
06/2010
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2010
1Primary Effusion Lymphoma
04/2010
1Glioma (Gliomas)
08/2009

Drug/Important Bio-Agent (IBA)

15P-GlycoproteinIBA
11/2015 - 12/2002
15Adenosine Triphosphate (ATP)IBA
01/2014 - 03/2002
13irinotecan (Camptosar)FDA LinkGeneric
07/2011 - 03/2002
12Mitoxantrone (Novantrone)FDA LinkGeneric
07/2011 - 02/2002
12Fluorouracil (Carac)FDA LinkGeneric
05/2009 - 12/2004
11Topotecan (Hycamtin)FDA LinkGeneric
07/2011 - 03/2002
9ATP-Binding Cassette Transporters (ABC Transporters)IBA
11/2015 - 01/2003
6gefitinib (Iressa)FDA Link
01/2014 - 09/2004
6DNA (Deoxyribonucleic Acid)IBA
04/2007 - 11/2002
5docetaxel (Taxotere)FDA Link
10/2007 - 04/2003
4Proteins (Proteins, Gene)IBA
11/2015 - 05/2005
4Messenger RNA (mRNA)IBA
01/2015 - 06/2005
4imatinib (Gleevec)FDA Link
01/2014 - 06/2003
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2014 - 01/2009
4Leucovorin (Folinic Acid)FDA Link
05/2009 - 12/2006
4Estrogens (Estrogen)FDA Link
03/2007 - 09/2003
3Paclitaxel (Taxol)FDA LinkGeneric
07/2011 - 12/2004
3Doxorubicin (Adriamycin)FDA LinkGeneric
07/2011 - 06/2005
3Carbon MonoxideIBA
05/2009 - 05/2003
3Folic Acid (Vitamin M)FDA LinkGeneric
05/2009 - 03/2007
3TegafurIBA
04/2007 - 06/2006
3UracilIBA
04/2007 - 06/2006
3capecitabine (Xeloda)FDA Link
04/2007 - 12/2004
3Estrone (Folliculin)FDA Link
11/2006 - 03/2002
3Orotate PhosphoribosyltransferaseIBA
06/2006 - 07/2005
2Transcription Factors (Transcription Factor)IBA
09/2012 - 04/2006
25' Untranslated Regions (5' UTR)IBA
09/2012 - 01/2012
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
09/2009 - 04/2009
2triacsin CIBA
08/2009 - 05/2005
2LigasesIBA
08/2009 - 05/2005
2Etoposide (VP 16)FDA LinkGeneric
08/2009 - 06/2005
2Acyl Coenzyme A (Acyl CoA)IBA
08/2009 - 05/2005
2FlavonoidsIBA
11/2007 - 06/2004
2claudin 16IBA
12/2006 - 12/2004
2Estrogen Receptor alphaIBA
11/2006 - 01/2005
2Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
06/2006 - 12/2004
2Cisplatin (Platino)FDA LinkGeneric
06/2006 - 06/2005
2Antineoplastic Agents (Antineoplastics)IBA
09/2005 - 06/2004
2PeptidesIBA
08/2005 - 05/2005
2Reverse Transcriptase InhibitorsIBA
10/2004 - 01/2003
2Indicators and Reagents (Reagents)IBA
09/2003 - 03/2002
2Complementary DNA (cDNA)IBA
06/2003 - 06/2002
1Epidermal Growth Factor (EGF)IBA
11/2015
1Plant ExtractsIBA
11/2015
1Complex MixturesIBA
11/2015
1resazurinIBA
11/2015
1damsinIBA
01/2015
1LactonesIBA
01/2015
1ApigeninIBA
01/2015
1archazolid BIBA
10/2014
1Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
10/2014
1sesaminIBA
04/2014
1triphosphoric acid (triphosphate)IBA
01/2014
1AdenineFDA LinkGeneric
01/2014
1Proteasome Endopeptidase Complex (Proteasome)IBA
06/2013
1UbiquitinIBA
06/2013
1telaprevirIBA
01/2013
1Isoleucine-tRNA LigaseIBA
01/2013
1Insulin (Novolin)FDA Link
09/2012
1A-factor (Streptomyces)IBA
09/2012
1CytosineIBA
09/2012
1sunitinib (Sutent)FDA Link
06/2010
1multidrug resistance-associated protein 1IBA
06/2010
1CyclinsIBA
04/2010
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2010
1Dihematoporphyrin Ether (Porfimer Sodium)FDA Link
02/2010
11-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2010
1Talaporfin (talaporfin sodium)IBA
02/2010
1Photosensitizing Agents (Photosensitizers)IBA
02/2010
1dofequidar (MS 209)IBA
11/2009
1Fatty Acids (Saturated Fatty Acids)IBA
08/2009

Therapy/Procedure

20Drug Therapy (Chemotherapy)
11/2015 - 04/2003
14Heterologous Transplantation (Xenotransplantation)
07/2011 - 12/2004
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2006 - 04/2003
2Therapeutics
11/2015 - 01/2014
2Transplants (Transplant)
07/2010 - 10/2007
1Transplantation (Transplant Recipients)
07/2010
1Photochemotherapy (Photodynamic Therapy)
02/2010